MCID: OVR046
MIFTS: 52

Ovarian Cyst

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Ovarian Cyst

Summaries for Ovarian Cyst

MedlinePlus : 44 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ovarian Cyst, also known as ovarian cysts, is related to corpus luteum cyst and ovarian disease, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MUC16 (Mucin 16, Cell Surface Associated), and among its related pathways/superpathways are Regulation of lipid metabolism Insulin signaling-generic cascades and Endometrial cancer. The drugs Ethinyl Estradiol and Cyproterone Acetate have been mentioned in the context of this disorder. Affiliated tissues include ovary, bone and brain, and related phenotypes are endocrine/exocrine gland and neoplasm

Disease Ontology : 12 An ovarian disease that is characterized by the presence of a fluid-filled sac and is located in the ovary.

Wikipedia : 77 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Related Diseases for Ovarian Cyst

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 156, show less)
# Related Disease Score Top Affiliating Genes
1 corpus luteum cyst 32.0 AFP FOXL2 MUC16
2 ovarian disease 31.0 FOXL2 MUC16 NOBOX PRL VEGFA
3 cystadenocarcinoma 29.8 MUC16 VEGFA
4 ovarian cancer 29.7 GSTP1 MUC16 PLAU VEGFA
5 adenomyosis 29.6 PRL VEGFA
6 neonatal ovarian cyst 12.4
7 malignant ovarian cyst 12.3
8 mccune-albright syndrome 11.4
9 fraser-like syndrome 11.1
10 aromatase deficiency 11.1
11 bleeding disorder, platelet-type, 19 11.1
12 autoimmune oophoritis 11.1
13 lipedematous scalp 11.1
14 breast cancer 10.3
15 opisthorchiasis 10.3 AFP MUC16
16 adenomatoid tumor 10.3 AFP MUC16
17 endodermal sinus tumor 10.3 AFP MUC16
18 testicular granulosa cell tumor 10.3 AFP FOXL2
19 juvenile type testicular granulosa cell tumor 10.3 AFP FOXL2
20 male reproductive organ benign neoplasm 10.3 AFP FOXL2
21 hydrocele 10.3 AFP VEGFA
22 peliosis hepatis 10.3 AFP VEGFA
23 primary peritoneal carcinoma 10.3 MUC16 VEGFA
24 telangiectasis 10.3 AFP VEGFA
25 hypothyroidism 10.2
26 pericardial effusion 10.2 MUC16 VEGFA
27 sex cord-gonadal stromal tumor 10.2 AFP FOXL2
28 serous cystadenocarcinoma 10.2 MUC16 VEGFA
29 placental insufficiency 10.2 AFP VEGFA
30 intratubular embryonal carcinoma 10.2 AFP PLAU
31 endometriosis 10.2
32 hepatic veno-occlusive disease 10.2 PLAT VEGFA
33 uterine anomalies 10.2 AFP VEGFA
34 meningocele 10.1
35 joint disorders 10.1 PLAU SERPINB2
36 ovarian brenner tumor 10.1 MUC16 PRL
37 ectopic pregnancy 10.1
38 granulosa cell tumor of the ovary 10.1 FOXL2 PRL
39 pituitary tumors 10.1 PRL VEGFA
40 gingivitis 10.1 PLAT SERPINB2
41 vein disease 10.0 AFP PLAT VEGFA
42 ovarian hyperstimulation syndrome 10.0
43 adenoma 10.0
44 ovarian epithelial cancer 10.0
45 pre-eclampsia 10.0 AFP SERPINB2 VEGFA
46 lipodermatosclerosis 10.0 PLAT SERPINB2 VEGFA
47 hydronephrosis 10.0
48 leiomyoma 10.0
49 intestinal obstruction 10.0
50 leiomyoma, uterine 9.9
51 lipoid congenital adrenal hyperplasia 9.9
52 thrombosis 9.9
53 neurilemmoma 9.9
54 polyhydramnios 9.9
55 pulmonary embolism 9.9
56 precocious puberty 9.9
57 female reproductive system disease 9.9 FOXL2 PRL VEGFA
58 adamantinoma of long bones 9.9 GSTP1 PLAU VEGFA
59 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.8
60 hydatidiform mole, recurrent, 1 9.8
61 ovarian cancer 1 9.8
62 diabetes mellitus 9.8
63 endometritis 9.8
64 teratoma 9.8
65 purpura 9.8
66 pseudomyxoma peritonei 9.8
67 gestational trophoblastic neoplasm 9.8
68 infertility 9.8
69 kidney disease 9.8
70 peritonitis 9.8
71 autosomal dominant polycystic kidney disease 9.8
72 polycystic kidney disease 9.8
73 breast disease 9.8 PLAU PRL VEGFA
74 male reproductive organ cancer 9.8 GSTP1 VEGFA
75 endometrial cancer 9.8 MUC16 PLAU SERPINB2 VEGFA
76 lung cancer susceptibility 3 9.7 GSTP1 PLAU VEGFA
77 bladder diverticulum 9.7
78 epicanthus 9.7
79 factor viii deficiency 9.7
80 intussusception 9.7
81 kabuki syndrome 1 9.7
82 marfan syndrome 9.7
83 neural tube defects 9.7
84 thrombophilia due to thrombin defect 9.7
85 anemia, autoimmune hemolytic 9.7
86 fraser syndrome 1 9.7
87 factor v deficiency 9.7
88 hemihyperplasia, isolated 9.7
89 hemophilia a 9.7
90 wilms tumor 5 9.7
91 neural tube defects, folate-sensitive 9.7
92 alpha-thalassemia 9.7
93 body mass index quantitative trait locus 1 9.7
94 chromosome 16p13.3 deletion syndrome, proximal 9.7
95 muscle hypertrophy 9.7
96 wilms tumor 6 9.7
97 hemolytic anemia 9.7
98 hydrocephalus 9.7
99 nephrolithiasis 9.7
100 polycystic ovary syndrome 9.7
101 thalassemia 9.7
102 ulcerative colitis 9.7
103 congenital hypothyroidism 9.7
104 inflammatory bowel disease 9.7
105 abdominal tuberculosis 9.7
106 ductal carcinoma in situ 9.7
107 pain agnosia 9.7
108 colitis 9.7
109 ptosis 9.7
110 inguinal hernia 9.7
111 cloacal exstrophy 9.7
112 pelvic inflammatory disease 9.7
113 blepharophimosis 9.7
114 supine hypotensive syndrome 9.7
115 disseminated intravascular coagulation 9.7
116 pyelonephritis 9.7
117 goiter 9.7
118 von willebrand's disease 9.7
119 mucocele of appendix 9.7
120 obstructive jaundice 9.7
121 toxic shock syndrome 9.7
122 gonadal dysgenesis 9.7
123 echinococcosis 9.7
124 ventricular septal defect 9.7
125 small intestine leiomyoma 9.7
126 cystic teratoma 9.7
127 chorioangioma 9.7
128 adenocarcinoma 9.7
129 lipomatosis 9.7
130 cellular schwannoma 9.7
131 ovarian cystadenocarcinoma 9.7
132 anovulation 9.7
133 pituitary adenoma 9.7
134 pelvic lipomatosis 9.7
135 myopathy 9.7
136 clear cell adenocarcinoma 9.7
137 uremia 9.7
138 acute pyelonephritis 9.7
139 pyosalpinx 9.7
140 compartment syndrome 9.7
141 thyroiditis 9.7
142 intestinal volvulus 9.7
143 in situ carcinoma 9.7
144 hemophilia 9.7
145 hypertrophic cardiomyopathy 9.7
146 3-beta-hydroxysteroid dehydrogenase deficiency 9.7
147 cervical intraepithelial neoplasia 9.7
148 congenital hydrocephalus 9.7
149 hemimegalencephaly 9.7
150 lymphomatous thyroiditis 9.7
151 pulmonary sequestration 9.7
152 foot drop 9.7
153 amenorrhea 9.7 NOBOX PRL
154 premature ovarian failure 1 9.6 FOXL2 NOBOX PRL
155 gonadal disease 9.6 AFP FOXL2 MUC16 PRL VEGFA
156 gastric cancer 9.4 AFP GSTP1 PLAU VEGFA

Graphical network of the top 20 diseases related to Ovarian Cyst:



Diseases related to Ovarian Cyst

Symptoms & Phenotypes for Ovarian Cyst

UMLS symptoms related to Ovarian Cyst:


pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

47 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.7 AFP FOXL2 NOBOX PLAT PLAU PRL
2 neoplasm MP:0002006 9.35 AFP PLAU PRL SERPINB2 VEGFA
3 reproductive system MP:0005389 9.17 AFP FOXL2 NOBOX PLAT PLAU PRL

Drugs & Therapeutics for Ovarian Cyst

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 389, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-63-6 5991
2
Cyproterone Acetate Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 427-51-0
3
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
4
Drospirenone Approved Phase 4,Phase 3,Phase 1,Not Applicable 67392-87-4 68873
5
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
6
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
7
Simvastatin Approved Phase 4,Phase 3,Not Applicable 79902-63-9 54454
8
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 1,Not Applicable 501-36-0 445154
9
Ganirelix Approved Phase 4,Early Phase 1 124904-93-4, 123246-29-7 25081094
10
Sodium Citrate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 68-04-2
11
Orlistat Approved, Investigational Phase 4,Phase 2 96829-58-2 3034010
12
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 112809-51-5 3902
13
Pioglitazone Approved, Investigational Phase 4,Not Applicable,Early Phase 1 111025-46-8 4829
14
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-05-9 143 6006
15
Acarbose Approved, Investigational Phase 4,Not Applicable 56180-94-0 441184
16
Zinc Approved, Investigational Phase 4,Early Phase 1,Not Applicable 7440-66-6 32051
17
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-83-0 5994
18
Hydrocortisone Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-23-7 5754
19
Hydrocortisone acetate Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-03-3
20
Glucagon Approved Phase 4,Phase 3,Not Applicable 16941-32-5
21
Testosterone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-22-0, 481-30-1 10204 6013
22
Toremifene Approved, Investigational Phase 4 89778-26-7 3005573
23
Tamoxifen Approved Phase 4,Phase 3 10540-29-1 2733526
24
Danazol Approved Phase 4 17230-88-5 28417
25
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
26
Liraglutide Approved Phase 4,Phase 3 204656-20-2 44147092
27
Menotropins Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 9002-68-0, 61489-71-2 5360545
28
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 616-91-1 12035
29
Citalopram Approved Phase 4 59729-33-8 2771
30
Racepinephrine Approved Phase 4,Not Applicable,Early Phase 1 329-65-7 838
31
Epinephrine Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 51-43-4 5816
32
Alogliptin Approved Phase 4 850649-61-5 11450633
33
Moxonidine Approved, Investigational Phase 4 75438-57-2 4810
34
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
35
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 15589840 11953898
36
Methylcobalamin Approved, Experimental, Investigational Phase 4,Not Applicable 13422-55-4
37
Leuprolide Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 53714-56-0 657181 3911
38
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
39
Rosiglitazone Approved, Investigational Phase 4,Not Applicable 122320-73-4 77999
40
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2 141758-74-9 15991534
41
tannic acid Approved Phase 4,Phase 2,Not Applicable,Early Phase 1 1401-55-4
42
Benzocaine Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
43
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 1177-87-3
44
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 50-02-2 5743
45
Medroxyprogesterone acetate Approved, Investigational Phase 4,Not Applicable 71-58-9
46
Desogestrel Approved Phase 4,Phase 3 54024-22-5 40973
47
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
48
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
49
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
50
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
51
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
52
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
53
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 77-92-9 311
54
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-70-2 271
55
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Not Applicable 67-97-0 5280795 6221
56
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1406-16-2
57
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-14-6 5280793
58
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 73-31-4 896
59
Calcifediol Approved, Nutraceutical Phase 4,Phase 3 19356-17-3 5283731 6433735
60
Alfacalcidol Approved, Nutraceutical Phase 4 41294-56-8 5282181
61
Niacin Approved, Investigational, Nutraceutical Phase 4 59-67-6 938
62
Manganese Approved, Nutraceutical Phase 4 7439-96-5 27854
63
Cyanocobalamin Approved, Nutraceutical Phase 4,Not Applicable 68-19-9 44176380
64
Inulin Approved, Investigational, Nutraceutical Phase 4,Phase 2 9005-80-5 24763
65 Deslorelin Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 57773-65-6
66
Enclomiphene Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 15690-57-0
67
Cobalamin Experimental Phase 4,Not Applicable 13408-78-1 6857388
68
2,4-thiazolidinedione Investigational Phase 4,Early Phase 1 2295-31-0
69
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
70 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
71 Triptorelin Pamoate Phase 4,Phase 3,Not Applicable
72 Luteolytic Agents Phase 4,Phase 3,Not Applicable
73 Contraceptive Agents Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
74 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
75 Drospirenone and ethinyl estradiol combination Phase 4,Phase 3,Phase 1,Not Applicable
76 Cyproterone acetate, ethinyl estradiol drug combination Phase 4,Phase 2,Not Applicable
77 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
78 Contraceptive Agents, Male Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable
79 Contraceptives, Oral, Combined Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
80
Cyproterone Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 2098-66-0 5284537
81 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
82 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
83 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
84 Natriuretic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
85 Hemostatics Phase 4,Phase 3,Phase 2,Not Applicable
86 Estrogens Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
87 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
88 diuretics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
89 Contraceptives, Oral Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
90 Androgens Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
91 Mineralocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
92 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
93 Androgen Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
94 Antioxidants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
95 Mineralocorticoid Receptor Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
96 Micronutrients Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
97 Nutrients Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
98 Trace Elements Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
99 Folate Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
100 Vitamin B9 Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
101 Vitamin B Complex Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
102 Vitamins Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
103 Hypoglycemic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
104 Lipid Regulating Agents Phase 4,Phase 3,Phase 2,Not Applicable
105 Platelet Aggregation Inhibitors Phase 4,Not Applicable
106 Anticholesteremic Agents Phase 4,Phase 3,Phase 2,Not Applicable
107 Analgesics Phase 4,Phase 2,Phase 1,Not Applicable
108 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1,Not Applicable
109 Antimetabolites Phase 4,Phase 3,Phase 2,Not Applicable
110 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
111 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
112 Hypolipidemic Agents Phase 4,Phase 3,Phase 2,Not Applicable
113 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1,Not Applicable
114 Antineoplastic Agents, Phytogenic Phase 4,Not Applicable
115 Antirheumatic Agents Phase 4,Phase 2,Phase 1,Not Applicable
116 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
117 Zuclomiphene Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
118 Citrate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
119 Clomiphene Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
120 Appetite Depressants Phase 4,Phase 3
121 Anti-Obesity Agents Phase 4,Phase 3,Phase 2
122 insulin Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
123 Insulin, Globin Zinc Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
124 Antidepressive Agents Phase 4
125 Psychotropic Drugs Phase 4
126 Estrogen Receptor Modulators Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
127 Estrogen Receptor Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
128 Chelating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
129 Estrogen Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
130 Selective Estrogen Receptor Modulators Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
131 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
132 Anticoagulants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
133 Fertility Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
134 Bone Density Conservation Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
135 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
136 Aromatase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
137 Calciferol Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
138 Ergocalciferols Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
139 Vitamin D2 Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
140 Incretins Phase 4,Phase 3,Phase 2,Not Applicable
141 Glucagon-Like Peptide 1 Phase 4,Phase 3,Not Applicable
142 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
143 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
144 Antiparkinson Agents Phase 4,Phase 3,Phase 2,Not Applicable
145 Hematinics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
146 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
147 Glycoside Hydrolase Inhibitors Phase 4,Not Applicable
148 Cardiac Glycosides Phase 4,Not Applicable
149 Liver Extracts Phase 4,Phase 2,Phase 3,Not Applicable
150 Progestins Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
151 Chorionic Gonadotropin Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
152 Follicle Stimulating Hormone Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
153 Hydrocortisone hemisuccinate Phase 4,Not Applicable,Early Phase 1
154 Hydrocortisone 17-butyrate 21-propionate Phase 4,Not Applicable,Early Phase 1
155 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable,Early Phase 1
156 Fenugreek Phase 4,Not Applicable
157 Fenugreek seed meal Phase 4,Not Applicable
158 Cyclooxygenase 2 Inhibitors Phase 4
159 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 1
160 Hydroxycholecalciferols Phase 4,Phase 3
161 Sitagliptin Phosphate Phase 4
162
protease inhibitors Phase 4,Phase 3,Early Phase 1,Not Applicable
163 Dipeptidyl-Peptidase IV Inhibitors Phase 4,Phase 3
164 HIV Protease Inhibitors Phase 4,Phase 3,Early Phase 1,Not Applicable
165 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
166 Phytoestrogens Phase 4
167 Phosphodiesterase Inhibitors Phase 4
168 Phosphodiesterase 4 Inhibitors Phase 4
169 carnitine Phase 4,Not Applicable
170 Mitogens Phase 4,Early Phase 1
171 Endothelial Growth Factors Phase 4,Early Phase 1
172 Angiogenesis Inducing Agents Phase 4
173 N-monoacetylcystine Phase 4,Phase 2,Phase 3,Not Applicable
174 Free Radical Scavengers Phase 4,Phase 2,Phase 3,Not Applicable
175 Antidotes Phase 4,Phase 2,Phase 3,Not Applicable
176 Antiviral Agents Phase 4,Phase 2,Phase 3,Not Applicable
177 cysteine Phase 4,Phase 2,Phase 3,Not Applicable
178 Respiratory System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
179 Expectorants Phase 4,Phase 2,Phase 3,Not Applicable
180 Parasympatholytics Phase 4
181 Muscarinic Antagonists Phase 4
182 Epinephryl borate Phase 4,Not Applicable,Early Phase 1
183 Antidepressive Agents, Second-Generation Phase 4
184 Serotonin Uptake Inhibitors Phase 4
185 Cholinergic Antagonists Phase 4
186 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
187 Cholinergic Agents Phase 4
188 Neurotransmitter Uptake Inhibitors Phase 4
189 Serotonin Agents Phase 4
190 Antihypertensive Agents Phase 4,Not Applicable
191 Nicotinic Acids Phase 4
192 Vitamin B3 Phase 4
193 Vasodilator Agents Phase 4,Not Applicable
194 Vitamin B12 Phase 4,Not Applicable
195 Vitamin B 12 Phase 4,Not Applicable
196 Olive Phase 4,Not Applicable
197 Antiemetics Phase 4,Phase 3,Not Applicable,Early Phase 1
198 glucocorticoids Phase 4,Phase 3,Not Applicable,Early Phase 1
199 BB 1101 Phase 4,Phase 3,Not Applicable,Early Phase 1
200
Medroxyprogesterone Phase 4,Not Applicable 520-85-4 10631
201 Tin Fluorides Phase 4
202 Acidophilus Phase 4,Phase 3,Not Applicable
203 Bifidobacterium Phase 4,Phase 3
204 Dacuronium Phase 4
205 Prednisolone acetate Phase 4
206 Methylprednisolone Acetate Phase 4
207 Neuroprotective Agents Phase 4
208
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
209
Dopamine Approved Phase 3,Phase 2,Not Applicable 62-31-7, 51-61-6 681
210
Bromocriptine Approved, Investigational Phase 3 25614-03-3 31101
211
Ropivacaine Approved Phase 3,Phase 2 84057-95-4 175805 71273
212
Morphine Approved, Investigational Phase 3 57-27-2 5288826
213 Cinnamon Approved Phase 3,Phase 1
214
Exemestane Approved, Investigational Phase 3 107868-30-4 60198
215
Saxagliptin Approved Phase 3 361442-04-8 11243969
216
Cetrorelix Approved, Investigational Phase 3,Not Applicable 120287-85-6 25074887 16129715
217
Calcium Carbonate Approved, Investigational Phase 3 471-34-1
218
Empagliflozin Approved Phase 2, Phase 3